ATE183311T1 - Für tests verwendbare chemilumineszierende ester, thioester und amide - Google Patents

Für tests verwendbare chemilumineszierende ester, thioester und amide

Info

Publication number
ATE183311T1
ATE183311T1 AT88121915T AT88121915T ATE183311T1 AT E183311 T1 ATE183311 T1 AT E183311T1 AT 88121915 T AT88121915 T AT 88121915T AT 88121915 T AT88121915 T AT 88121915T AT E183311 T1 ATE183311 T1 AT E183311T1
Authority
AT
Austria
Prior art keywords
ring
linkage
ring system
substituent groups
heterocyclic ring
Prior art date
Application number
AT88121915T
Other languages
English (en)
Inventor
Frank Mccapra
Iraj Beheshti
Russell C Hart
Harlen Koelling
Ashokkumar Patel
Kastooriranganath Ramakrishnan
Original Assignee
Nichols Inst Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26837818&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE183311(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nichols Inst Diagnostics filed Critical Nichols Inst Diagnostics
Application granted granted Critical
Publication of ATE183311T1 publication Critical patent/ATE183311T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/10Aza-phenanthrenes
    • C07D221/12Phenanthridines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
AT88121915T 1987-12-31 1988-12-30 Für tests verwendbare chemilumineszierende ester, thioester und amide ATE183311T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14004087A 1987-12-31 1987-12-31
US29184388A 1988-12-29 1988-12-29

Publications (1)

Publication Number Publication Date
ATE183311T1 true ATE183311T1 (de) 1999-08-15

Family

ID=26837818

Family Applications (2)

Application Number Title Priority Date Filing Date
AT88121915T ATE183311T1 (de) 1987-12-31 1988-12-30 Für tests verwendbare chemilumineszierende ester, thioester und amide
AT98123411T ATE425970T1 (de) 1987-12-31 1988-12-30 Testverfahren mit verbesserten chemilumineszierenden estern, thioestern und amiden

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98123411T ATE425970T1 (de) 1987-12-31 1988-12-30 Testverfahren mit verbesserten chemilumineszierenden estern, thioestern und amiden

Country Status (14)

Country Link
EP (2) EP0322926B2 (de)
JP (1) JP3172522B2 (de)
KR (1) KR900700888A (de)
AT (2) ATE183311T1 (de)
AU (1) AU635890B2 (de)
CA (1) CA1341613C (de)
DE (3) DE3891212T1 (de)
ES (1) ES2134185T5 (de)
GB (4) GB2232995B (de)
GR (1) GR3031647T3 (de)
IE (1) IE61614B1 (de)
IL (1) IL88848A (de)
NZ (1) NZ227506A (de)
WO (1) WO1989006231A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918192A (en) * 1986-10-06 1990-04-17 Ciba Corning Diagnostics Corp. Polysubstituted aryl acridinium esters
DE3750503T2 (de) * 1986-10-22 1995-02-09 Abbott Lab Chemilumineszierende Acridinium- und Phenantridiniumsalze.
US4950613A (en) * 1988-02-26 1990-08-21 Gen-Probe Incorporated Proteted chemiluminescent labels
WO1989012232A1 (en) * 1988-06-08 1989-12-14 London Diagnostics, Inc. Assays utilizing sensitizer-induced production of detectable signals
US5656426A (en) * 1988-08-01 1997-08-12 Chiron Diagnostics Corporation Functionaized hydrophilic acridinium esters
US5227489A (en) * 1988-08-01 1993-07-13 Ciba Corning Diagnostics Corp. Stable hydrophilic acridinium esters suitable for liposome encapsulation
US5663074A (en) * 1988-09-26 1997-09-02 Chiron Diagnostics Corporation Nucleophilic polysubstituted aryl acridinium ester conjugates and syntheses thereof
CA1339491C (en) * 1988-09-26 1997-10-07 Say-Jong Law Nucleophilic polysubstituted aryl acridinium ester and uses thereof
US5340716A (en) * 1991-06-20 1994-08-23 Snytex (U.S.A.) Inc. Assay method utilizing photoactivated chemiluminescent label
JPH07509245A (ja) * 1992-07-20 1995-10-12 デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 新規化学発光化合物およびその使用方法
US6002000A (en) * 1992-07-20 1999-12-14 Dade Behring Marburg Gmbh Chemiluminescent compounds and methods of use
WO1994003812A1 (en) * 1992-07-31 1994-02-17 Syntex (U.S.A.) Inc. Photoactivatable chemiluminescent matrices
JP3584379B2 (ja) * 1993-02-04 2004-11-04 持田製薬株式会社 アクリジニウム化合物およびアクリジニウム化合物複合体
US5395752A (en) * 1993-03-19 1995-03-07 Ciba Corning Diagnostics Corp. Long emission wavelength chemiluminescent compounds and their use in test assays
US5491072A (en) * 1993-05-17 1996-02-13 Lumigen, Inc. N-alkylacridan carboxyl derivatives useful for chemiluminescent detection
US5393891A (en) * 1993-06-08 1995-02-28 The Du Pont Merck Pharmaceutical Company Immunoassay reagents and methods for detecting brequinar and analogs
US5731148A (en) * 1995-06-07 1998-03-24 Gen-Probe Incorporated Adduct protection assay
EP0761652A1 (de) * 1995-08-01 1997-03-12 Mochida Pharmaceutical Co., Ltd. Acridiniumverbindung mit mehreren lumineszierenden Gruppen und Bindungsgruppen und Konjugate derselben
DE69711188T2 (de) * 1996-07-16 2002-09-05 Nederlanden Staat Dibenzodihydropyridincarbonsäureester und ihre anwendung in chemolumineszenz-untersuchungsverfahren
US6165800A (en) * 1997-05-30 2000-12-26 Bayer Corporation Chemiluminescent energy transfer conjugates and their uses as labels in binding assays
EP1019379B1 (de) * 1997-08-21 2005-10-19 Maine Medical Center Auf peroxiden basierender chemilumineszenztest und chemilumineszente verbindungen die in diesem benutzt werden
US6723851B2 (en) * 2001-10-31 2004-04-20 Quest Diagnostics Investment Incorporated Chemiluminescent compounds and use thereof
DE102005020384A1 (de) * 2005-05-02 2006-11-09 Therainvention Gmbh Spektroskopisches Verfahren zum Nachweis von Analyten

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1461877A (en) * 1974-02-12 1977-01-19 Wellcome Found Assay method utilizing chemiluminescence
EP0082636B2 (de) * 1981-12-11 2006-10-18 The Welsh National School of Medicine Lumineszierende Markierungssubstanzen und -verfahren
US4687747A (en) * 1984-07-02 1987-08-18 Mallinckrodt, Inc. Phenanthridinium ester as a labelling compound in luminometric immunoassay
JPS6261969A (ja) * 1985-09-06 1987-03-18 アモコ・コーポレーション アクリジニウムエステルの合成法
DE3645292C2 (de) * 1986-08-22 1997-12-11 Hoechst Ag Chemilumineszenzimmunoassays und ein Verfahren zu ihrer Herstellung
US4745181A (en) * 1986-10-06 1988-05-17 Ciba Corning Diagnostics Corp. Polysubstituted aryl acridinium esters
DE3750503T2 (de) * 1986-10-22 1995-02-09 Abbott Lab Chemilumineszierende Acridinium- und Phenantridiniumsalze.
ES2074051T3 (es) * 1987-09-21 1995-09-01 Gen Probe Inc Ensayo de proteccion homogeneo.
NL8703075A (nl) 1987-12-18 1989-07-17 Nederlanden Staat Acridiniumverbindingen als chemiluminescentie-merkstof.

Also Published As

Publication number Publication date
IE883895L (en) 1989-06-30
ES2134185T5 (es) 2004-11-01
EP0322926B2 (de) 2004-03-31
DE3891212T1 (de) 1991-01-10
EP0916658A1 (de) 1999-05-19
GR3031647T3 (en) 2000-02-29
ATE425970T1 (de) 2009-04-15
EP0322926A3 (de) 1991-03-20
NZ227506A (en) 1992-06-25
KR900700888A (ko) 1990-08-17
GB2251942A (en) 1992-07-22
AU635890B2 (en) 1993-04-08
GB9203181D0 (en) 1992-04-01
GB2232995B (en) 1992-10-14
DE3856358D1 (de) 1999-09-16
AU2927089A (en) 1989-08-01
IL88848A (en) 1994-02-27
EP0916658B1 (de) 2009-03-18
GB2252161A (en) 1992-07-29
IE61614B1 (en) 1994-11-16
DE3856597D1 (de) 2009-04-30
JPH03501772A (ja) 1991-04-18
GB9203179D0 (en) 1992-04-01
DE3856358T3 (de) 2004-12-30
WO1989006231A1 (en) 1989-07-13
CA1341613C (en) 2011-05-10
EP0322926A2 (de) 1989-07-05
JP3172522B2 (ja) 2001-06-04
DE3856358T2 (de) 2000-04-20
GB2252162A (en) 1992-07-29
GB9014479D0 (en) 1990-10-03
EP0322926B1 (de) 1999-08-11
GB9203180D0 (en) 1992-04-01
IL88848A0 (en) 1989-07-31
GB2232995A (en) 1991-01-02
ES2134185T3 (es) 1999-10-01

Similar Documents

Publication Publication Date Title
ATE183311T1 (de) Für tests verwendbare chemilumineszierende ester, thioester und amide
HUP0102475A2 (hu) Új acil-pszeudopeptidek, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
FI955438A0 (fi) N-asyylisulfamidihappoesterit (tai -tioesterit), N-asyylisulfonamidit ja N-sulfonyylikarbamiinihappoesterit (tai -tioesterit) hyperkolesteroleemisina aineina
ES2115665T3 (es) Derivado de triterpeno.
KR870000288A (ko) (메트)-아크릴산 에스테르의 제조방법
DE3177284D1 (de) Organische phosphinsaeureverbindungen.
ATE38675T1 (de) Phosphatesterderivate und ihre verwendung als anti-krebsmittel.
ES8304120A1 (es) Un procedimiento para la preparacion de nuevos derivados de acilaminoquimazolina.
NZ189091A (en) Prostaglandin derivatives
DK0381628T3 (da) Glycocyamidinderivater
FI850215L (fi) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl- n-furyl(eller tienyl)-metylpropylaminer.
DK564788D0 (da) 2-azetidinon-derivater
ATE19634T1 (de) Phosphonsaeureester.
ES466305A1 (es) Un procedimiento para la preparacion de una sal con un ami- noazucar basico o un aminoacido basico, de un derivado de benzopirano.
DK54180A (da) Fremgangsmaade til fremstilling af xanthonderivater
SE7900889L (sv) Sett att framstella xantonderivat
GB1478070A (en) Esters of o-alkyloxycarbonyl and o-alkylthiocarbonyl- naphthohydroxamic acids their preparation and their miticidal compositions comprising them
TH22461A (th) อนุพันธ์พิเพอร์คิล-ไทรอาซีน ชนิดใหม่และการใช้สารทำให้โพทำให้โพลิเมอร์เสถียร
ES264962A1 (es) Procedimiento de obtencion de un blanqueador optico
TH22461EX (th) อนุพันธ์พิเพอร์คิล-ไทรอาซีน ชนิดใหม่และการใช้สารทำให้โพทำให้โพลิเมอร์เสถียร

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification

Ref document number: 0322926

Country of ref document: EP

EELA Cancelled due to lapse of time